Zhejiang Meton Pharmaceutical Co., LTD., established in 2020 and based in Hangzhou, China, is dedicated to innovative drug discovery. Benifiting from the long-time research experience of our scientists in cancer metabolism, Meton’s current R&D strategy is to target tumor-related metabolic enzymes for potential therapeutic solutions. We have built up a comprehensive discovery platform and our team with professional expertise is keeping all projects advancing in fast track. So far, all projects are on the way from lead* optimization to PCC. Innovative, original R&D in compliance with law and regulation are believed to embody our values and fulfill our visions.
*Patent No.: PCT/CN2016/090022,PCT/CN2016/107098